Cargando…

Recent advances in Brucella abortus vaccines

Brucella abortus vaccines play a central role in bovine brucellosis control/eradication programs and have been successfully used worldwide for decades. Strain 19 and RB51 are the approved B. abortus vaccines strains most commonly used to protect cattle against infection and abortion. However, due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorneles, Elaine MS, Sriranganathan, Nammalwar, Lage, Andrey P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495609/
https://www.ncbi.nlm.nih.gov/pubmed/26155935
http://dx.doi.org/10.1186/s13567-015-0199-7
_version_ 1782380278591782912
author Dorneles, Elaine MS
Sriranganathan, Nammalwar
Lage, Andrey P.
author_facet Dorneles, Elaine MS
Sriranganathan, Nammalwar
Lage, Andrey P.
author_sort Dorneles, Elaine MS
collection PubMed
description Brucella abortus vaccines play a central role in bovine brucellosis control/eradication programs and have been successfully used worldwide for decades. Strain 19 and RB51 are the approved B. abortus vaccines strains most commonly used to protect cattle against infection and abortion. However, due to some drawbacks shown by these vaccines much effort has been undertaken for the development of new vaccines, safer and more effective, that could also be used in other susceptible species of animals. In this paper, we present a review of the main aspects of the vaccines that have been used in the brucellosis control over the years and the current research advances in the development of new B. abortus vaccines.
format Online
Article
Text
id pubmed-4495609
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44956092015-07-09 Recent advances in Brucella abortus vaccines Dorneles, Elaine MS Sriranganathan, Nammalwar Lage, Andrey P. Vet Res Review Brucella abortus vaccines play a central role in bovine brucellosis control/eradication programs and have been successfully used worldwide for decades. Strain 19 and RB51 are the approved B. abortus vaccines strains most commonly used to protect cattle against infection and abortion. However, due to some drawbacks shown by these vaccines much effort has been undertaken for the development of new vaccines, safer and more effective, that could also be used in other susceptible species of animals. In this paper, we present a review of the main aspects of the vaccines that have been used in the brucellosis control over the years and the current research advances in the development of new B. abortus vaccines. BioMed Central 2015-07-08 2015 /pmc/articles/PMC4495609/ /pubmed/26155935 http://dx.doi.org/10.1186/s13567-015-0199-7 Text en © Dorneles et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Dorneles, Elaine MS
Sriranganathan, Nammalwar
Lage, Andrey P.
Recent advances in Brucella abortus vaccines
title Recent advances in Brucella abortus vaccines
title_full Recent advances in Brucella abortus vaccines
title_fullStr Recent advances in Brucella abortus vaccines
title_full_unstemmed Recent advances in Brucella abortus vaccines
title_short Recent advances in Brucella abortus vaccines
title_sort recent advances in brucella abortus vaccines
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495609/
https://www.ncbi.nlm.nih.gov/pubmed/26155935
http://dx.doi.org/10.1186/s13567-015-0199-7
work_keys_str_mv AT dorneleselainems recentadvancesinbrucellaabortusvaccines
AT sriranganathannammalwar recentadvancesinbrucellaabortusvaccines
AT lageandreyp recentadvancesinbrucellaabortusvaccines